Basic information

Biomarker: SPAG9

Histology type: endometrial carcinoma

Stage: early stage

Cohort characteristics

Country: China

Region: Shandong

Followed up time :

Subgroup 1 name : positive in EC

Subgroup 1 number: 36

Subgroup 2 name: negative in EC

Subgroup 2 number: 14

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
59 EC 47 adjacent noncancerous tissues 12 atypical hyperplasia 10 normal endometrium 22

Sample information

Conclusion: SPAG9 is positively expressed in endometrial cancer, and with a high humoral immune response in patients. It may serve as a new type of endometrial cancer markers for early detection, diagnosis and treatment

Sample type : tissue

Sample method: reverse transcriptase-polymerase chain reaction, immunohistochemistry Western blot

Expression pattern : expression

Disease information

Related information

Funtion Uniprot: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:14743216). Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex (PubMed:29146937). Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity).

UniProt ID: O60271

UniProt Link: https://www.uniprot.org/uniprotkb/O60271/entry

Molecular function from UniProt:

Tissue specificity from UniProt: Expressed only in testis on the round spermatids of stage I, II and II. Absent in spermatogonia and spermatocyte. Isoform 4 Expressed in testis and in acute myeloid leukemia (AML) patients. Isoform 3 Expressed in testis.

Subcellular UniProt: #Cytoplasm #Cytoplasmic vesicle #Lysosome #Membrane

Alternative name from UniProt:

Activity regulation: Isoform 5 May play a role in spermatozoa-egg-interaction.

Recommended name: C-Jun-amino-terminal kinase-interacting protein 4

Gene name from HGNC: SPAG9 (CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1)

HPA class: Plasma proteins

AlphaFold DB: O60271

AlphaFold Link: https://alphafold.ebi.ac.uk/entry/O60271

HPA link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14524

Tissue specificity RNA from HPA: Low tissue specificity

Tissue expression from HPA: Ubiquitous cytoplasmic expression.

Single cell type specificity Low cell type specificity

Immune cell specificity: Group enriched (neutrophil, basophil)

Subcellular summary HPA Located in Centriolar satellite, Cytosol

Cancer prognostic summary HPA Prognostic marker in urothelial cancer (unfavorable)

Pathology link: https://www.proteinatlas.org/ENSG00000008294-SPAG9/pathology

Pathology endo: https://www.proteinatlas.org/ENSG00000008294-SPAG9/pathology/endometrial+cancer

OMIM: 605430

OMIM link2: https://www.omim.org/entry/605430

HGNC ID: HGNC:14524

HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14524

Visulization